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ABSTRACT
Purpose To verify the robustness and fundamental value of
Atomic Force Microscopy (AFM) and AFM-based assays to
rapidly examine the molecular homogeneity and physical stabil-
ity of amorphous solid dispersions on Hot-Melt-Extrudates.
Methods Amorphous solid dispersions were prepared with a
Hot-Melt Extruder (HME) and profiled by Raman Microscopy
and AFM following a sequential analytical routine (Multi-Scale-
Imaging-of-Miscibiliy (MIMix)). Extrudates were analyzed before
and after incubation at elevated temperature and humidity. The
data were compared with published results as collected on
miniaturized melt models. The value of molecular phase sepa-
ration rates for long term stability prediction was assessed.
Results Data recorded on the extrudates are consistent with
those published, and they can be compared side by side. Such
direct data comparisons allow the identification of possible sources
of extrudate heterogeneities. The surface roughness analysis of
fracture-exposed interfaces is a novel quantitative way to trace on
the nanometer scale the efficiencies of differently conducted
HME-processes. Molecular phase separation rates are shown to
be relevant for long term stability predictions.
Conclusions The AFM-based assessment of API:excipient
combinations is a robust method to rapidly identify miscible
and stable solid dispersions in a routine manner. It provides a
novel analytical tool for the optimization of HME processes.
KEY WORDS amorphous solid dispersion . atomic force
microscopy . hot melt extrusion . process optimization .
stability prediction
ABBREVIATIONS
AFM Atomic Force Microscopy
API Active Pharmaceutical Ingredient
CETP(Inh) CETP Inhibitor
DSC Differential Scanning Calorimetry
Eudragit L100 Polymethacrylate
HME Hot-Melt-Extrusion
HPMCAS MF Hydroxypropyl methylcellulose acetate
succinate
MIMix Multi Scale Imaging of Miscibility
NK1(Ant) NK1 Antagonist
PHR Phase Homogeneity Ratio
PVP K30 Polyvinylpyrrolidone K30
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INTRODUCTION
Amorphous solid dispersions can increase the oral bioavail-
ability of poorly water soluble drugs. The drug molecules are
intended to be conserved amorphously in a matrix, typically of
polymeric excipients, ideally in the form of homogenously
dispersed, dissolved molecules. Single dispersed drug mole-
cules do not have the physico-chemical properties widely
associated with their bulk ensembles, crystals or other bulk
volume phases. Many physical material properties are
changed in an amorphous state, for example, the dissolution
behavior, thermal and mechanical properties, spectroscopic
properties and even the specific density of the material (1).
A well-known disadvantage of amorphous solid dispersions
is the lack of thermodynamic stability, as small and poorly
soluble drug molecules often have a high potential to crystal-
lize out. One topic of fundamental research is to identify and
to better understand amorphous drug-polymer systems which
offer an appropriate and uniform dissolution performance in-
vivo, and which also can be prevented from phase separation in
the solid state on the long term. It is convenient to screen for
such systems usingminiaturized formulationmodels accessible
by quench-cooling of drug-excipient melt mixtures (2,3), or by
various casting methods (4–7) .
Physical stability studies are usually time-consuming, as
phase separation in the solid state is a comparatively slow
physical process, its velocity depending on many factors,
including the initial dispersion structure, thermal diffusion
coefficients, the drug-polymer interaction and the corre-
sponding phase mobilities, and the crystal nucleation energy
of the drug. A critical amount of sufficiently sized drug and
excipient phases needs to have formed to change the overall
physical properties of a material significantly.
Many established analytical methods to routinely char-
acterize amorphous solid dispersions examine properties
which are relevant only to bulk packed molecular ensem-
bles, rather than of dissolved molecules. X-ray powder dif-
fraction (XRPD), for instance, typically verifies the nature
and amount of diffracting crystals within already critical
mixtures (8). Differential Scanning Calorimetry (DSC) typ-
ically inspects for the presence of heterogeneous bulk phase
properties at a given temperature and time, with the initial-
origin system constitution often unknown (9). Classical opti-
cal methods such as polarization microscopy and Raman
Imaging reveal heterogeneity information of single regions
with a resolution in the range of the wavelength of light
(10,11). None of these methods delivers information about
the detailed spatial molecular structure of these systems, the
phase homogeneity and properties on the nanometer scale.
None of these methods is intended to differentiate between
the surface and the volume properties of a material. The
highly complex nature of solid dispersions is typically char-
acterized by the absence of physical properties potentially
observable by complementary analytical methods (12). It is a
widely appreciated analytical challenge to directly differen-
tiate between similarly composed but differently prepared
and performing amorphous solid dispersion systems using
only the “bulk-averaging“analytical techniques (13).
High-Resolution Imaging Technologies provide information
on the level of single particles rather than displaying the proper-
ties of larger material sections and bulk packed particle ensem-
bles. Scanning Electron Microscopy (SEM) is preferably applied
to image particles of complex morphologies with an inherently
better resolution than classical optical microscopy (14). Atomic
Force Microscopy (AFM) provides better spatial resolution on
soft organic material surfaces, but is operatively restricted to
rather smoothly shaped sample surfaces and small particles. Such
cantilever-based methods have, however, their attractiveness as
they allow the examination of molecular surface landscapes and
surface properties in an ambient environment, directly and
nondestructively. AFM data are metrological rather than pho-
tographic in nature and can, for instance, be easily quantified in
respect to the molecular surface roughness (15).
Phase mapping, as it is routinely conducted with AFM
under tapping-mode operations, is well established for the
qualitative display of mechanical material heterogeneity
contrasts (16). Tapping AFM can also be performed in an
automated and high throughput manner. Other cantilever-
based sensing modes (17), such as Peak Force Quantitative
Mapping (18), nano-thermal AFM (19), or Nano-IR (20) can
be applied when information beyond that of a qualitative
binary phase heterogeneity is required.
AFM –based methods have been established to charac-
terize amorphous systems (21–23). They were recently help-
ful to identify low quantities of phase-separated drugs in
Hot-Melt-Extrudates (24), or to characterize the surfaces
of particles obtained by spray drying (25). We have shown
that AFMs can be applied in an assay manner, and for
instance, two drug compounds could be recently profiled
within a set of five polymeric excipients with respect to their
molecular miscibility and physical stabilities in a parallelized
and systematic workflow, MIMix (26).
MIMix utilizes fundamentally different imaging technol-
ogies (Raman Imaging and AFM) that are operated at
different resolution regimes to visualize surface phase con-
stitutions on the micrometer and on the nanometer length
scales. MIMix comprises three basic and hierarchically or-
ganized analytical working steps. Firstly, MIMix examines
fracture-exposed bulk interfaces for spatial-spectroscopic
uniformity on the micrometer scale using confocal Raman
Imaging. Secondly, these fracture-exposed molecular land-
scapes are probed with the AFM to determine the phase
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homogeneity status on the nanometer scale. The molecular
morphology is determined on 3×3 μm2-sized surface sec-
tions and on different sample regions. The morphological
deviation from the image mean plane is expressed in terms
of a root mean square roughness, and the variability of
different regions on the sample is expressed as the standard
deviation. The mechanical property contrast is sensed by
recording phase maps by AFM tapping-mode operation.
These maps are additionally inspected for nanometer-sized
features, which are indicative of separated phases. Only
amorphous solid dispersions exhibiting a surface roughness
and deviation similar to or smoother than that of the corre-
sponding pure excipient blank, and which are also feature-
less in the phase images, are then considered to be of a
molecular homogenous structure, and only those are here
termed to fulfill the MIMix homogeneity criteria. Thirdly,
the last MIMix step consist of stress tests (accelerated stabil-
ity test) to finally determine and compare small-sized struc-
tural changes within the surface phase constitutions such as
may introduced by applied environmental stress or storage
time on a time scale of hours.
The assay and MIMix workflow was developed to exam-
ine the intrinsic melt miscibility and stability of a given drug
within various excipients using freshly-fractured quench-
cooled melt mixtures (“QCMM”). This novel AFM ap-
proach and the data gathered are encouraging, as they
can provide a novel analytical way of better comparing
and ranking differently composed dispersion systems in
an objective fashion. This approach and its concepts,
however, have at the moment not in general been
proven to accelerate and facilitate formulation research
on amorphous material.
It is currently unknown how structure–property relations
determined from surfaces on the nanometer scale and using
QCMMs might compare with those generated by
established processes such as Hot-Melt-Extrusion. It is
unclear to which extent phase separation rates examined
on fracture-exposed bulk interfaces on the molecular scale
are reproducible, how sensitive such surfaces structures are
to environmental changes, and whether the results gen-
erally compare with those amorphous systems processed
by different means. It is clear that these questions in-
volve some methodological issues, as it is necessary to
compare objectively amorphous surface structures of
differently composed, structured or processed systems.
Another fundamental requirement is to show that mo-
lecular phase separation rates determined within hours
are predictive of long-term macroscopic material stabil-
ities of dispersion systems processed by completely dif-
ferent means.
These unresolved issues were the motivation to process
two previously profiled drugs, an NK1 Antagonist and a
CETP inhibitor with a small-scale Hot-Melt Extruder, and
to subject those to the previously proposed MIMix workflow
(26). The extrudate data are compared side-by-side with
those of the assay published previously.
MATERIALS AND METHODS
Compound Selection
The selection of Active Pharmaceutical Ingredients
(APIs) and excipients was that of compounds screened
previously (26). An NK1 Receptor Antagonist, which
will be referenced to as NK1(Ant) (27), and a CETP
Inhibitor (28), which will be referenced to as CETP(Inh)
were selected there. NK1(Ant) has a melting point (Tm)
of Tm=130°C: the melting point of CETP(Inh) is Tm=
142°C. NK1(Ant) has a higher tendency to crystallize
and was known to be more difficult to stabilize than
CETP(Inh). The glass transition temperature and crys-
tallization tendencies are shown with Differential Scan-
ning Calorimetry in Supplementary Material (29). The
excipient selection focused on the polymer class and five
different polymers were chosen: the copolymer of 1-
vinyl-2-pyrrolidone and vinyl acetate (PVP VA 64,
BASF, Ludwigshafen, Germany); Polyvinylpyrrolidone
K30 (PVP K30, BASF, Ludwigshafen, Germany);
Polyvinylpyrrolidone PF17 (PVP PF17, BASF, Ludwigshafen,
Germany); Hydroxypropyl methylcellulose acetate succinate
type M (HPMCAS MF, Shin-Etsu, Tokyo, Japan) and
Polymethacrylate (Eudragit L100, Evonik Industries AG, Es-
sen, Germany). To enable the side by side comparison of the
here prepared extrudates with the previously profiled
QCMMs the same API:excipient ratio of 1 : 1 has been
applied (26).
HME
The extrudates were prepared with a small-scale Hot
Melt Extruder. A DSM Micro 5 Compounder (DSM
Xplore, Geleen, The Netherlands) with co-rotating twin
screw and 5 mL batch-volume with recirculation chan-
nel was used. The Extruder has 4 heating zones; upper
and lower zone with independent front and rear adjust-
ments. The drug-polymer mixtures were weighted in the
selected proportion (1:1), gently mixed in a mortar (dry)
and sieved through a 0.6 mm screen. 5 g of each
physical blend mixture were loaded into the extruder
at 120°C (all 4 zones) at a screw speed of 100 rpm
within ~5 min. Mixing was allowed during 5–10 min at
140°C (all 4 zones) and 100 rpm by recirculation. The
temperature was then adjusted to 120°C to increase the
viscosity and the extrusion was conducted at a screw
speed of 50 rpm.
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Preparation of Extrudates for the RI and AFM
Investigations
For microscopic investigations fresh and smoothly fractured
extrudate surfaces are required.Horizontally aligned
fracture surfaces were generated after introducing
predetermined fracture points on the outer surfaces of the
extrudates. All extrudates had the form of cylindrical bodies,
pieces 1 and 1.5 cm long and of 0.5 cm width were selected,
and placed on a sheet of paper. A razor blade was lightly
pushed onto the surface of the extrudate and the cylindrical
body moved and rolled under the razor blade. This gave the
extrudate surfaces a pre-determined breaking point, a closed-
circular scratch, ~ 0.5 mm deep. Fracture was then intro-
duced by bending the extrudates with the use of two tweezers.
The freshly fractured extrudates were mounted on an optical
glass slide by use of a 2 component epoxy resin, which hard-
ened within ~5 min. Before the hardening reaction had been
completed the extrudate orientation was corrected to get the
fracture surface as horizontal as possible. This step is manda-
tory to enable non-destructive imaging and automated sample
changing within Atomic Force Microscope operations.
Stability studies were carried out on freshly fractured
extrudates. The samples were stored at accelerated stability
conditions (T=40°C, RH=75%) for 2 h. Before stress stor-
age the mounted extrudates were brought to a temperature
of T=40°C to minimize the risk of unspecific moisture
condensation during incubation. The surfaces were stressed
in a pre-equilibrated desiccator having a static room humid-
ity (RH) of 75% (saturated solution of sodium chloride) and
a temperature of T=40°C. The stress storage time is the
effective storage time at RH=75%, T=40°C. Finally the
samples were quickly removed from the humid, high tem-
perature environment and “dried” in a vacuum chamber.
MIMix Workflow
The objective was the inspection and comparison of
fracture-exposed extrudate interfaces with those described
previously for the corresponding QCMM, using the same
MIMix workflow as summarized above (26).
Raman Imaging
Raman mapping experiments were performed on a
LabRAM ARAMIS (HoribaJobinYvon) Raman microscope
equipped with a Peltier cooled CCD detector using laser
excitation at 785 nm and a 600 1/mm grating centered at
1,100 cm−1 (wave number range 450–1,730 cm−1) . For
each sample at least 441 (21×21) spectra were recorded in
an area of 80×80 μm2 using a 50x objective (Olympus; NA
0.75). Settings were chosen to guarantee a spatial resolution
of at least 5 μm (size of measurement spot for a single
Raman spectrum). All Raman spectra of one mapping ex-
periment were evaluated by integration of bands typical for
API or excipient in the mixture. Homogeneity was judged
by the ratio variation of API and excipient. The full data set
is shown in Supplementary Material.
Atomic Force Microscopy
Freshly fractured extrudates on microscopic glass slides were
mounted on the micrometer positioning stage of a Dimension
Icon AFM (Bruker, Santa Barbara). Between 10 and 25 re-
gions per sample were programmed to be automatically char-
acterized using the software routine “programmed move” in
Tapping Mode (Bruker Nansocope V8 r1.5). Height, phase,
and amplitude images were collected simultaneously, using
etched silicon cantilevers with a nominal spring constant of
k=20–80 N/m (Bruker AFM Probes, RTESPA). The typical
free vibration amplitude was in the range of A=25 nm, the
images were recorded with set-point amplitudes correspond-
ing to 60–70% of the free amplitude. Image areas of 3×3 μm2
were recorded at a resolution of 1,024×1,024 pixels. All data
were batch-processed using Scanning Probe Image Processor
(SPIP 5.1.1). Height data were plane-corrected by applying a
3rd order polynomial fit. Molecular fracture roughness data as
displayed in the Figs. 3 and 6 show the root mean square
roughness and standard deviation calculated from at least 20
images on each sample. The roughness parameters reflect the
variation with respect to the topography mean height. The
phase images shown are non-processed raw data.
RESULTS
Figure 1 shows the chemical structure of the NK1 receptor
antagonist, and of the CETP inhibitor. Both APIs had been
Fig. 1 Chemical structure of selected APIs. NK1 receptor antagonist (1),
and CETP inhibitor (2).
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profiled for their intrinsic melt-miscibility within a set of five
different excipients (PVP VA64, PVP K30, HPMCAS MF,
PVP PF17, Eudragit L100), and at a fixed drug load of 50%.
The melt-miscibility had been determined on QCMMs. The-
se were prepared from glassy films, which were melt-
homogenized at T=180°C before quench-cooling (26).
These ten combinations were processed here with a small
scale Hot-Melt Extruder (HME) as described above. The ten
combinations were processed with the same extruder, applying
comparable feed and screw speeds, and at a comparable tem-
perature operation window ranging from T=120°C to 140°C.
MIMix Homogeneity
The micrometer homogeneity of the extrudates, which is
examined in the first working step of MIMix, is shown in
comparison with that of the corresponding QCMMs in
Table I. Three of the ten extrudates prepared have an irreg-
ular spatial API distribution on the micrometer scale, as
examined by Raman Imaging (Supplementary Material).
Nanometer homogeneity, which is accessed in the second step
of MIMix, is observed in only two of the seven remaining
combinations: the NK1(Ant) : PVP PF17, and the CETP(Inh)
: HPMCAS MF extrudate. The nanometer homogeneity of
all extrudates and of the published QCMMs is shown and
compared with the roughness charts in Fig. 2, and the corre-
sponding recorded AFM phase maps in Figs. 3 and 4.
The surface roughness variations quantitatively match
those of the QCMMs for the NK1(Ant) : PVP PF17 extrudate
(Fig. 2a), and for the CETP(Inh) : HPMCASMF extrudate, as
well as the CETP(Inh) : PVP VA64 extrudate (Fig. 2b). The
four other extrudates are different; they are only micrometer-
homogenous. In these cases the surfaces are, if compared with
the QCMMs, rougher, and/or the roughness measured on
different sample regions is divergent. The absolute roughness
and/or the regional deviations (variance) are accordingly
larger, and do not match that of the corresponding and
homogenously constituted QCMM.
However, the AFM phase maps which were recorded on
the extrudates additionally indicate that only the NK1(Ant) :
PVP PF17 and the CETP(Inh) : HPMCAS MF extrudates
fully compare with their corresponding QCMM (Figs. 3d, i
and 4c, h). Only those two extrudates strictly fulfilled all of
the introduced MIMix homogeneity criteria.
The CETP(Inh) : PVP VA64 extrudate (Fig. 4a, f) is close
to homogeneous, with only a sole nanometer-sized droplet
found within the 25 independently inspected surface regions.
This is depicted by a Phase-Homogeneity-Ratio (PHR) of
1/25 as directly shown in the phase map (Fig. 4f). The PHR
relates the amount of phase maps showing a distinct feature (as
shown in the image) with the amount of overall recordedmaps
(all the other phase maps recorded were featureless, and are
not shown here). The PHR indicates how representative the
map shown is. All other extrudates are more critically inter-
spersed with nanometric features with many phase maps
showing features not typical for homogenous mixtures. Ap-
parently most of the prepared extrudates have not reached the
homogeneity that is possible or had been previously achieved
with the QCMM preparation.
Process Optimization
In order to identify whether the homogeneity that is achieved
in the QCMMs can also be achieved by means of hot melt
extrusion, the NK1(Ant) combination with PVP VA64 was
extruded at a higher mixing temperature of T=160°C. The
surface roughness of this higher temperature extrudate was
measured and compared with its heterogeneous analogue
extruded at T=140°C, and with the corresponding QCMM
results in the Fig. 5.
The higher process temperature results in a similar frac-
ture roughness and variance, a surface status similar to that
found using the QCMM (Figs. 2a and 3a). The sample
roughness data match quantitatively, with the fracture-
exposed bulk interfaces of the high temperature extrudate
clearly smoother and more uniform than when extruded at
T=140°C.
MIMix Stress Test
The third and last step of the MIMix workflow was to
analyze all the homogenously constituted extrudates in re-
spect of their potential to phase separate in a humidity stress
environment. We selected here three extrudates, all meeting
Table I Spatial API/Excipient Distribution of Assay and HME Dispersion Systems as Examined with Confocal Raman Imaging
PVP VA 64 PVP K 30 HPMCAS MF PVP PF 17 Eudragit L 100
NK1(Ant) assay homo. homo. homo. homo. hetero.
NK1(Ant) HME homo. homo. hetero. homo. hetero.
CETP(Inh) assay homo. homo. homo. homo. homo.
CETP(Inh) HME homo. homo. homo. homo. hetero.
homo.: uniform API/excipient distribution on the micrometer scale
hetero. non-uniform API/excipient distribution on micrometer scale
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or almost meeting the MIMix homogeneity criteria
(CETP(Inh ) : PVP VA, NK1(Ant ) : PVP PF17,
CETP(Inh):HPMCAS MF). These three extrudates were
freshly fractured before being exposed to accelerated stress
conditions of RH=75%, and T=40°C, for 2 h. 10 different
locations on each extrudate were then re-inspected by tapping-
mode AFM for stress-storage introduced phase separation
patterns. In Fig. 6 the phase separation patterns observed are
comparedwith those of the correspondingly stressedQCMMs.
The phase separation patterns evolved on the extrudates
and QCMM are comparable for each API : excipient sys-
tem. The patterns do not depend on the way how the
systems have been prepared. The NK1(Ant)-based systems
had previously been described to undergo spinodal de-
mixing, with the stressed surface uniformly decorated with
the characteristic bimodal patterns (Fig. 6a,b). In contrast,
the CETP systems tended to undergo de-mixing by nucle-
ation and growth (Fig. 6c-f). Isolated spots can then be
observed, which were shown to grow and crystallize with
time previously (26). The domain size and separation length
of the evolved bimodal patterns on the NK1(Ant) extrudate
(Fig. 6b) are comparable with those of the NK1(Ant)
QCMMs (Fig. 6a) (26). The size and amount of detected
nanoparticles, in relation to the total of the imaged area, is
on the CETP-based extrudates comparable with that of the
corresponding QCMMs (Fig. 6c-d and e-f). 5 out of 25
imaged regions are spiked with nanoparticles in case of the
CETP(2):PVP VA64 QCMM (6e), and 3 out of 15 imaged
regions are decorated with particles on the corresponding
extrudate (6f). The situation on both CETP(Inh) :
HPMCAS MF systems is comparable as well (Fig. 6c-d).
To estimate the fundamental impact of the initial homoge-
neity status on molecular de-mixing processes within similarly
composed systems, the following experiment was performed.
The three differently prepared and differently constituted
NK1(Ant) : PVP VA64 systems as shown in the Fig. 5, were
Fig. 2 The Root Mean Square roughness of freshly fractured API-excipient
extrudates is compared with that of QCMMs and excipient blanks pub-
lished previously (25). (a) Root Mean Square Roughness and standard
deviations of all investigated NK1(Ant) systems and the corresponding
excipient blanks, (b) Root Mean Square Roughness and standard deviations
of all CETP(Inh) systems and corresponding excipient blanks.
Fig. 3 Nanometer homogeneity of freshly fractured NK1(Ant) QCMMs (top row) is compared with corresponding extrudates phase maps as they were
recorded with tapping-mode AFM: top row (a-e) was recorded on the QCMMs published previously, bottom row is (f-j) recorded on the corresponding
extrudates. The numbers visible in the image rows (a-e, and f-j) relate the amount of comparably structured places with the amount of investigated area (PHR).
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stressed for 2 h at RH=75%, and T=40°C. The evolved
decomposition patterns are compared side by side in Fig. 7.
The bimodal patterns of the QCMM (Fig. 7a) and of the
homogenous extrudate (Fig. 7b) are comparable. The sur-
face of the heterogeneous/low-temperature extrudate is dif-
ferent (Fig. 7c). After stress storage the initial, frequently
noticed, droplet-like spots (Fig. 3f), have become decorated
with particles of needle like or grainy morphology (Fig. 7c).
These particles often provide a detectably harder mechan-
ical contrast within the AFM phase maps (harder sample
regions can appear whiter in the maps). Taken together it
appears, that the de-mixing process of a API:excipient
composition depends on both the possible homogeneity
status of the dispersion system and on the process history.
To roughly estimate the macroscopic relevance of our
nanometers-scaled and surface-restricted AFM studies, the
overall quick aging NK1(Ant) extrudates (independent of
whether they were homogenous or not) were subjected to
3 month–scaled stress exposures (RH =75%, T=40°C).
Photographs of the stressed extrudates were recorded. In
Fig. 8 the published assay ranking results for the NK1
systems (Fig. 8e), are compared with the macroscopically
observed whitening of their corresponding extrudate photo-
graphs taken after 3 months.
The HPMCAS MF-based NK1(Ant) system showed
slower de-mixing than all PVP-based sample systems
(Fig. 8e). The HPMCAS extrudate preserved its glassy ap-
pearance on the millimeter scale (Fig. 8a). In contrast the
PVP K30-based system, which de-mixed rapidly in the
published assay, is found from the macroscopic perspective
to be clearly de-mixed (Fig. 8d, e).
DISCUSSION
Amorphous solid dispersion is an umbrella term for different
kinds of amorphous mixtures, often classified by their ther-
modynamic phase behavior. In pharmaceutical research,
solid dispersions are also distinguished in regard to their
dissolution properties (30). Binary drug-polymer mixtures,
when they have been prepared by solvent casting, typically
belong in the class of “transparent glassy amorphous solid
solutions”. To absolutely and objectively compare different-
ly composed, structured or prepared solid dispersions, pre-
viously only characterized with purely static imaging data,
Fig. 4 Nanometer homogeneity of freshly fractured CETP(Inh)-QCMMs (top row) is compared with corresponding extrudate, phase maps as they were
recorded with tapping-mode AFM: top row (a-e) was recorded on the QCMMs published previously(f-j), bottom row is recorded on the corresponding
extrudates. The numbers visible in the image rows (a-e, and f-j) relate the amount of comparably structured places with the amount of investigated area (PHR).
Fig. 5 Homogeneity comparison of similarly composed and differently
processed NK1(Ant)-PVP VA64 dispersions on basis of their molecular
surface roughness.
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another and phenomenological classification concept was
applied.
MIMix Classification System
Analyzing all the AFM phase data recorded within this
study (> 600 phase maps), only three different types of
molecular heterogeneity constitutions could be recognized
(Fig. 9a): Class A1, Class A2, and Class B.
Class A1 Dispersion
Both components are tightly and continuously intermixed on
the nanometer scale. They fulfill the MIMix homogeneity
criteria and are characterized by uniform and flat phase maps.
Their surface roughness and variance is typically smaller than
that of the applied excipient alone.We will introduce the term
“continuously-homogenously mixed systems” for these types
of solid dispersion.
Class A2 Dispersion
The excipient matrix is mainly continuously structured; howev-
er, critical spots are occasionally recognized. The appearance of
local spots on a subset of recorded images is indicated by a PHR
not equal to one. A2-class systems have a surface roughness and
variance exceeding that of the A1-class dispersions. They are
here termed “discontinuously-mixed solid dispersion systems”.
Fig. 6 Comparison of phase
separation processes of the
homogenously constituted
QCMM and extrudate systems
after exposure to stress
conditions (RH=75%, T=
40°C) for 2 h. The initial and
homogenous states are shown in
Figs. 4 and 5 for comparison. The
numbers visible in the images
relate the amount of comparably
structured places with the




This third group contains all dispersion systems of a continuous-
heterogeneous phase constitution: they can be termed “de-mixed
solid dispersion systems”. The surface roughness and variance
can exceed that of the polymer systems, and all phase maps are
of continuously heterogeneous contrast (PHR=1).
The MIMix homogeneity classes (A1, A2, and B) now
enable a better assessment of the efficiencies of the two different
preparation processes. If the QCMMs are compared pairwise
with the extrudates, only three of the nine theoretically possible
class combinations are observed: A1-A1, A1-A2, and B-B
(QCMM - HME), as illustrated in Fig. 9b-c. Combinations
such as B-A1, or A2-A1 do not appear. In other words, it was so
far not possible to record data on the extrudates where the
MIMix homogeneity is better than of the QCMMs. They have
a higher probability to reflect the intrinsically possible
Fig. 7 Comparison of phase separation processes of differently prepared
NK1(Ant):PVP VA64 systems after exposure to stress conditions (RH=
75%, T=40°C) for 2 h (samples of Fig. 6): (a) pattern as observed on
QCMMs, (b) patterns as observed on homogenously constituted HME
samples prepared at T =160°C, (c) pattern as observed on a heteroge-
neously constituted HME sample prepared at T =140°C. The numbers
visible in the images relate the amount of comparably structured places
with the amount of investigated area (PHR).
Fig. 8 Phase separation patterns as observed on NK1(Ant) QCMMs after
2 h scaled stress exposure to RH =75%, T=40°C (left column) are
opposed with photographs of corresponding extrudates stressed at similar
conditions for 3 months (a-d). (e) Phase separation velocities and stability
ranking as communicated previously.
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miscibility/immiscibility of a given API within the excipient
systems considered. This fundamental finding supports our
previous hypothesis that melt-homogenized solvent cast films
are likely to reflect the intrinsic miscibility of the considered
API:excipient in a melt state (26). This hypothesis has recently
been verified on Naproxen/PVP K25 solid dispersions (31).
The QCMMs are thus not only a practical preparation
system for screening purposes (26), but also their molecular
homogeneity status reflects most likely a miscibility opti-
mum. As the MIMix homogeneity data of QCMMs and
extrudates can be compared side by side, they are a novel
basis to benchmark the homogeneity basically accessible
with an optimized HME process. Taken together the knowl-
edge is very helpful to judge and to compare objectively the
efficiencies of differently conducted HME processes.
An A1-A1 situation indicates that the HME process has
reached the homogeneity that is close to the API : excipient
miscibility in a melt state. Melt miscibility was only realized
here in the NK1(Ant) - PVP PF17, and the CETP(Inh) –
HPMCAS MF extrudates. Most other extrudates belong to
class A2. The homogeneity achieved in the extrusion process
is inferior to that possible in the melt state (Fig. 9b). Accord-
ingly, A1-class extrudates are the desired ones. Extrudates of
class A2 must not be excluded from further formulation
development, but the HME process needs to be refined.
Extrudates assigned to class B were so far not suitable.
The PHR is a parameter which may be used to estimate
the details and differences of different A2 classes in a semi-
quantitative manner. The NK1(Ant) : PVP VA64 extrudate
is, for example, when compared with the NK1(Ant) : PVP
K30 system, more heterogenous. 13 out of 25 recorded
phase maps show separated spots, with only 3 out of the
25 recorded maps in the PVP-K30-based system. The PHR
enables an extension of the classification system introduced.
The NK1(Ant) : PVP64 extrudate can be said to exhibit an
A2-(13/25) state, whereas the NK1(Ant): PVP K30
Fig. 9 MIMix classification
system. (a) Schematic phase
maps as they are typically
recorded on solid dispersion




heterogeneous (B). (b) list of
QCMM: extrudate class
combinations so far observed
with MIMix. (c) Scheme to
illustrate the class combinations
theoretically possible.
(Combinations that have been
observed are outlined yellow.)
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extrudate shows an A2-(3/25) state. This MIMix classifica-
tion system provides a simple basis to better oversee, com-
pare, track, and communicate such comparatively huge sets
of phase maps in an easy and direct way.
Process Refinement, Roughness Analysis
Many different aspects need to be considered to identify the
most appropiate excipient in order to prepare a well
performing amorphous solid dispersion. A large scale HME
processes is, however, defined at a fixed drug load, and within
an already identified excipient system. The surface roughness,
which is most practically to determine on QCMMs, is a
quantitative parameter to benchmark and to compare abso-
lutely and quantitatively the efficiency of differently conducted
extrusion processes (Fig. 5). This is demonstrated here on the
NK1(Ant) - PVP VA64 – based systems. The surface rough-
ness of the high temperature extrudate quantitatively matches
that measured on the QCMM with impressive precision
(Fig. 5), the same extrudate is MIMix heterogeneous (A2 class)
when extruded at T=140°C (Fig. 5).
The MIMix roughness concept of excipients and of A1-
class mixtures can be understood intuitively with a simplistic
physical model, which is based upon the fundamental concept
of the free volume theory of polymers: the polymer as excip-
ient has a much larger size than a usual API. Fracture-exposed
bulk interfaces consisting of large building blocks are, for
purely geometric reasons, rougher (Fig. 10b) than those con-
stituted exclusively from small molecules. A1-class mixtures,
when the polymer matrix is homogenously inter-diffused with
small molecules, typically expose smoother bulk interfaces
than pure polymer excipients (Fig. 10a). The drug molecules
can act as small “gap-fillers” (32,33). The A2-class and B-class
mixtures are interspersed with nanoparticles of several API
molecules. If such particles reach a size range comparable to,
or bigger, than that of the polymer molecules, the fracture
surface becomes rougher. Different regions of the sample will
show a bigger variability (Fig. 10c).
This purely geometric packing consideration is a coarse
approximation. It can model most of our results in a
phenomenological manner. A comprehensive model would
need to take additional factors like the excipient and API
interactions, the conformational freedom of differently sized
or structured polymers, the rigidity or persistence of polymeric
backbones, the fracture mechanics and possible surface relax-
ation processes, which can be expected to occur during or
after fracturing, into account. They are here not discussed
further (34).
However, from the pragmatic point of view the magni-
tude of the surface roughness variation expresses the specific
physical properties of the excipient/polymer systems consid-
ered: in all API:excipient mixtures investigated here, it does
not noticeably depend on the nature of the API. The rough-
ness data of all A1-class NK1(Ant) mixtures quantitatively
compare with those of the corresponding A1-class
CETP(Inh)-based mixtures (Fig. 2a-b). The roughness anal-
ysis can deliver a novel parameter allowing to better com-
pare the molecular homogeneity of differently prepared
systems in a reproducible manner. However, the parameter
is only helpful as long as dispersion systems of one and the
same polymer system are considered, where the roughness
can be compared in absolute terms.
Stress Tests and Molecular Phase Separation Rates
Accelerated stability studies are generally used to identify
appropriate excipients for formulation development. The
AFM-based assay here tested all the extruded combinations
in this respect. To verify whether the published data of the
QCMMs indeed reflect a reproducible and intrinsic potential
of the API: excipient system considered, the same stability
study was carried out on extrudates. Two hour scaled stress
exposure was already sufficient to recognize on the nanometer
scale the different potentials of the extrudates to physically de-
mix when humid (Fig. 6). However, only the A1-class
extrudates compare well in detail with their corresponding
QCMMs. Firstly, in a qualitative way, as identical phase
separation mechanisms are observed: spinodal phase separa-
tion patterns were seen on all NK1(Ant)-QCMMs (Fig. 6 a, b),
whereas, in contrast, the CETP(Inh)-QCMMs de-mixed by
nucleation and growth (Fig. 6c-f). Secondly, they compare in a
quantitative way, as the amount of separated particles (nucle-
ation and growth) or the separation distances (spinodal phase
separation) are comparable. A2 and B-class extrudates, how-
ever, are more poorly defined and are found difficult to
reproduce experimentally (Fig. 7).
The possible impact of the MIMix homogeneity on the
molecular phase separation mechanism is shown explicitly for
the different NK1(Ant):PVP VA64 systems. The homogeneity
status of these three differently prepared systems is depicted in
Fig. 5. The decomposition patterns evolving on the A1-class
extrudate (processed at the higher temperature of T=160°C)
match with those of the QCMM. The A2-class extrudate
Fig. 10 Simplified model to illustrate the concept of surface roughness
and the drug smoothening effect on homogenous mixtures. (a) Models a
homogenous situation, the smaller molecules are dispersed between the
bigger polymer molecules. (b) Models the situation of polymer blank. (c)
Models a heterogeneous situation and shows domains of small molecule
aggregates bigger than the polymer.
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(extruded at T=140°C) is different. The stressed A2-class
extrudate frequently shows crystallized droplets and features.
(Fig. 8c), and the bimodal patterns are likewise variable.
If some API is initially condensed within droplets before the
exposure to stress storage, the dispersion matrix lacks this
amount of API. The potential of a mixture to phase separate,
however, directly depends on the API concentration in the
excipient matrix. It is clear from a fundamental point of view
that an already de-mixed system (A2- and B-class) inevitably de-
mixes, ages and performs differently than its A1-class analogues.
The MIMix stability data recorded in A1 state QCMMs
reflect a reproducible potential of the API: excipient system
considered (Fig. 7). However, solid dispersions which do not
have an identical homogeneity status in the beginning, age
differently. The MIMix homogeneity data, the roughness
and the classification concept introduced are fundamental
for such studies. They enable observation, identification and
comparison of such small structural differences in a consis-
tent and direct manner.
As most of the extrudates represented A2 homogeneity
states, it was not straightforward to carefully validate and
compare their physical stability using bulk analytical tech-
niques. Overall the NK1 systems age more rapidly than the
CETP-based systems. The underlying phase separation
mechanism, which is a spinodal phase separation process
in NK1(Ant)-based systems seems to be the reason. In a
spinodal process the whole material surface has to de-mix
uniformly and in concerted fashion. A larger amount of API
can be expected to segregate in a short amount of time (35),
and nucleation and growth acts only locally (36). To roughly
estimate the basic validity of our MIMix prediction concept,
all the NK1 extrudates (whether they are molecularly ho-
mogenous or not) were exposed for 3 months to accelerated-
stress conditions. Photographs were then recorded (Fig. 8).
This purely phenomenological approach is a direct and
simple way to identify materials which are obviously de-
mixed on macroscopic length scales. Phase separating
glasses undergo whitening and, over time, become turbid.
The NK1(Ant) : HPMCAS MF was previously predicted
to be the most stable NK1(Ant) combination (Fig. 8a). The
corresponding photographed extrudate maintained the
overall glassy appearance macroscopically. All the PVP-
based extrudates underwent whitening, apparently gradual-
ly. They are more turbid. The AFM data – photograph
comparison in Fig. 8 reminds us, that even the 2-
dimensional restricted phase separation processes depend
on the specific and intrinsic phase separation potentials of
the API: excipient system considered (37). These potentials
can comparatively be studied with the AFM in few hours on
representative model surfaces, on QCMMs. The MIMix
stability data are thus an analytical basis to rapidly identify
API: excipient systems having a low potential to phase
separate on the long term.
CONCLUSIONS
The MIMix concept allows the verification, comparison and
classification of the molecular homogeneity of differently
composed, constituted or processed amorphous solid disper-
sions in a direct and rational manner. Two different types of
observation, which can easily be accessed by tapping-mode
AFM, are found to be robust enough. Firstly, AFM phase
maps, which directly visualize the phase homogeneity con-
stitution of the mixture, and, secondly, AFM height maps,
which allow to determine the specific molecular surface
roughness of the API: excipient system considered.
The MIMix classification system enables the side by side
comparison of various solid dispersion systems and the iden-
tification of sources of molecular heterogeneity. Heterogene-
ity, which can be caused by poorly miscible API: excipient
combinations, can be distinguished from heterogeneity intro-
duced by a poorly optimizedHME process.MIMix roughness
analysis is a convenient tool to compare quantitatively the
molecular homogeneity within one and the same excipient
system when samples are prepared by different means. The
roughness analysis is helpful to guide the selection and refine-
ment of a given extrusion process at the technical level.
MIMix stability data, which can be gathered in minia-
turized QCMMs within only hours, compare well with the
stability of the corresponding extrudate system observed not
just after hours but also after months. The general applica-
bility of AFM and the AFM assay to rapidly identify
API:excipient systems which are physically stable on the
long term should be taken into consideration wherever
possible.
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